Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 50INDUSTRY 40NIH 7NETWORK 2OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 13Gynecologic 1

Conditions

Uterine Cervical Neoplasms 96Ovarian Neoplasms 54Endometrial Neoplasms 36Carcinoma, Ovarian Epithelial 22Fallopian Tube Neoplasms 19Neoplasms 11Uterine Cervical Dysplasia 9Papillomavirus Infections 7Recurrence 6Ovarian Cysts 6Vulvar Neoplasms 5Lymphatic Metastasis 5Uterine Neoplasms 4Peritoneal Neoplasms 4Gynecologic Cancer 4Colonic Neoplasms 4Pancreatic Neoplasms 3Malnutrition 3Hereditary Breast and Ovarian Cancer Syndrome 3Esophageal Neoplasms 3Endometrial Hyperplasia 3Carcinoma 3Breast Neoplasms 3Anxiety Disorders 3Stomach Neoplasms 2Radiation Injuries 2Polycystic Ovary Syndrome 2Peripheral Nervous System Diseases 2Patient Compliance 2Pain 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Liver Neoplasms × Gynecologic × Clear all
NCT07106814 2025-09-15

Safety and Efficacy of Metabolically Armed Tumor-lnfiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors

Anhui Provincial Hospital

Phase EARLY_PHASE1 Recruiting
36 enrolled
GastrointestinalGynecologic

Uterine Cervical Neoplasms, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡